CLEARSTEM recalled 4,890 bottles of YOU ARE SUNSHINE SPF 50 sunscreen on October 10, 2025. The recall follows concerns over CGMP deviations. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
CGMP Deviations
Consumers and healthcare providers should stop using this product immediately. Contact CA BOTANA International, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is CLEARSTEM YOU ARE SUNSHINE SPF 50, containing 21% Zinc Oxide, packaged in 2.1 oz (61g) bottles. The product is distributed by CLEARSTEM Skincare and has an NDC of 35192-046-17. The affected lot number is D54447, with an expiration date of November 30, 2027.
The recall stems from CGMP deviations, which are violations of current good manufacturing practices. These deviations may compromise the product's safety and efficacy, posing potential health risks to consumers.
No specific incidents or injuries have been reported related to this recall. The FDA identifies this recall as a Class II, indicating a moderate risk to health.
Consumers and healthcare providers should stop using this product immediately. For guidance, contact CA BOTANA International, Inc. A notification letter will be sent to affected consumers.
For more information about this recall, consumers can visit clearstemskincare.com or contact CA BOTANA International, Inc. directly.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.